Australian Competition and Consumer Commission v Jones (No 5)

Link copied
Case Copied 58 min read

FEDERAL COURT OF AUSTRALIA

Australian Competition and Consumer Commission v Jones (No 5)
[2011] FCA 49

Citation: Australian Competition and Consumer Commission v Jones (No 5) [2011] FCA 49
Parties: AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v DARRYL PETER JONES
File number: QUD 54 of 2010
Judge: LOGAN J
Date of judgment: 4 February 2011
Catchwords:

HIGH COURT AND FEDERAL COURT – Apprehension of bias as a result of past findings as to credit of the respondent – Where application for Judge to not conduct trial was withdrawn – Whether Judge should of his own motion not to conduct the trial – Where no findings as to credit were required to be made in the course of the trial

Held:  No need in circumstance to refrain from hearing trial

PRACTICE AND PROCEDURE – Application by respondent to adjourn the trial – When trial dates had been fixed six months in advance – Where proceeding involved a matter touching on public health – Where respondent also requested that the case be dealt with as soon as possible – Where next available hearing date would have involved considerable delay – Where no offer was made by the respondent to pay the applicant’s costs thrown away by any adjournment

Held:  In the interests of justice not to adjourn the trial

EVIDENCE – Affidavit evidence – Admissibility of opinions in articles annexed to affidavit (of the respondent) which were not authored by the deponent – Where applicant would not have had opportunity to cross-examine the authors of the articles in question – Where unfairness to the applicant could have occurred were the opinion evidence to be admitted

Held:  The articles not be admitted into evidence

TRADE PRACTICES – Misleading or deceptive conduct – Whether respondent engaged in misleading or deceptive conduct in the contravention of s 52 or s 53(c) of the Trade Practices Act 1974 (Cth) – Where respondent represented that his “program” could be followed to cure cancer – Where representations were admitted – Where the applicant led medical opinion evidence probative of a conclusion that the admitted representations were misleading or deceptive – Where respondent led neither compelling medical evidence nor evidence to support the kind of intuitive reasoning outlined in EMI (Australia) Ltd v Bes (1970) 2 NSWR 238

Held:  The representations were misleading or deceptive

Legislation: Evidence Act 1995 (Cth) s 79
Federal Court of Australia Act 1976 (Cth) ss 21, 37M
Trade Practices Act 1974 (Cth) ss 6, 52, 53
Cases cited: Aon Risk Services Australia Limited v Australian National University (2009) 239 CLR 175 cited
Australian Competition and Consumer Commission v Jones (No 3) [2010] FCA 908 cited
Ebner v Official Trustee in Bankruptcy (2000) 205 CLR 337 cited
EMI (Australia) Ltd v Bes (1970) 2 NSWR 238 considered
Foster v Australian Competition and Consumer Commission (2006) 149 FCR 135 applied
George v Rockett (1990) 170 CLR 104 cited
Johnson v Johnson (2000) 201 CLR 488 cited
Jones v Australian Competition and Consumer Commission [2010] FCAFC 136 cited
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Australian Competition and Consumer Commission v Jones (No 5... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2011] FCA 49
Decision Date

CaseChat Overview and Summary

The case before the court was brought by the Australian Competition and Consumer Commission (ACCC) against Jones, concerning allegations of misleading or deceptive conduct under sections 52 and 53(c) of the Trade Practices Act 1974 (Cth). Jones had made representations on the internet suggesting that reducing or eliminating glucose from the diet, and taking laetrile, could treat or prevent cancer. The ACCC sought declarations and injunctive relief against these claims, arguing they were misleading and deceptive and lacked a reliable scientific or medical basis.

The court addressed several procedural and substantive issues. Firstly, it considered whether the trial judge should recuse himself due to past findings regarding Jones's credibility, which were not relevant to the current trial. The court found no basis for recusal. Secondly, the court declined to adjourn the trial, despite Jones's request, as the trial dates had been set well in advance and the matter involved significant public health implications. Thirdly, the court ruled that certain articles annexed to Jones's affidavit, which were not authored by him, should not be admitted as evidence due to the lack of opportunity for the ACCC to cross-examine the authors.

On the substantive issue of misleading or deceptive conduct, the court found that Jones's representations were indeed misleading or deceptive. The ACCC presented medical opinion evidence that the claims were unfounded, while Jones failed to provide compelling medical evidence or intuitive reasoning to support his assertions. The court concluded that the representations contravened sections 52 and 53(c) of the Trade Practices Act.

The court granted the ACCC's requests for declaratory and injunctive relief, prohibiting Jones from making certain claims about cancer treatments unless supported by written advice from qualified medical professionals. Jones was also required to take steps to prevent others from making similar representations on his behalf and to publish a notice on his websites highlighting the court's findings. The comprehensive relief aimed to protect consumers from misleading health claims and ensure compliance with the Trade Practices Act.

Orders

Orders of the court

Declaratory Relief

1. The respondent, in trade or commerce, and in relation to the supply or possible supply or promotion of the supply of goods and services by the respondent, by making representations on the internet that:

1.1. the reduction or elimination of glucose from the diet;

1.1.1. was effective in the treatment or prevention of cancer;

1.1.2. had been proven to bring even the worst cancers under control; and

1.1.3. was, together with an exercise program recommended by him, more effective in treating cancer than pharmaceutical drugs, radium therapy, surgery and chemotherapy;

1.2. taking laetrile, also known as amygdalin, also referred to as "vitamin B17";

1.2.1. was effective in the treatment or prevention of cancer;

1.2.2. had been proven to bring even the worst cancers under control; and

1.2.3. was, together with an exercise program recommended by him, more effective in treating cancer than pharmaceutical drugs, radium therapy, surgery and chemotherapy;

1.3. there were reasonable grounds to make the representations referred to in paragraph 1.1 and 1.2 hereof; and

1.4. there was a reliable and current scientific or medical basis to make the representations referred to in paragraph 1.1 and 1.2 hereof;

when:

1.5. the reduction or elimination of glucose from the diet;

1.5.1. was not effective in the treatment of cancer;

1.5.2. had not been proven to bring even the worst cancers under control; and

1.5.3. was not, together with an exercise program recommended by him, more effective in treating cancer than pharmaceutical drugs, radium therapy, surgery and chemotherapy;

1.6. the taking of laetrile;

1.6.1. was not effective in the treatment or prevention of cancer;

1.6.2. had not been proven to bring even the worst cancers under control; and

1.6.3. was not, together with an exercise program recommended by him, more effective in treating cancer than pharmaceutical drugs, radium therapy, surgery and chemotherapy;

1.7. there were no reasonable grounds for making any of the representations referred to in paragraph 1.1 and 1.2 hereof; and

1.8. there were no reliable, current scientific or medical bases for any of the representations referred to in paragraph 1.1 and 1.2 hereof;

in the case of each of the said representations at 1.1, 1.2, 1.3 and 1.4 hereof:

1.9. engaged in conduct that was misleading or deceptive or likely to mislead or deceive in contravention of section 52 of the Trade Practices Act 1974 (Cth) (TPA); and

1.10. represented that his goods or services have uses or benefits they do not have in contravention of section 53(c) of the TPA.

Injunctive Relief

2. The respondent be restrained permanently, whether by himself or his servants or agents or otherwise howsoever:

2.1. in the course of trade or commerce between Australia and places outside Australia, among the States, within a Territory, between a State and a Territory or between two Territories; and

2.2. in trade or commerce involving the use of internet, postal, telegraphic or telephonic services or taking place in a radio or television broadcast;

from making any representation to the effect that the occurrence or growth of cancer or any medical condition can be prevented or successfully treated by any means whatsoever unless the respondent:

2.3. first has obtained:

2.3.1. from a person then registered with a medical practitioners board to practice medicine in Australia; or

2.3.2. from a professor, associate professor, reader, senior lecturer, or lecturer then teaching or researching in medicine at an Australian university;

written advice certifying that the proposed treatment is in the opinion of that person supported by reliable scientific evidence or expert medical opinion and is believed to be effective and safe; and

2.4. at the time of making the representation, prominently discloses details of the said advice, including the name, qualifications and position of the person providing the said advice; and

2.5. retains a copy of the said advice and provides a copy of the same to the applicant within 7 days of him receiving the certificate.

3. The respondent be permanently restrained, whether by himself or his servants or agents or otherwise howsoever, from knowingly being involved with, consenting to or encouraging the making of, by:

3.1. any person or unincorporated entity:

3.1.1. in the course of trade or commerce between Australia and places outside Australia, among the States, within a Territory, between a State and a Territory or between two Territories; or

3.1.2. in trade or commerce involving the use of internet, postal, telegraphic or telephonic services or taking place in a radio or television broadcast; or

3.2. any corporation, in trade or commerce;

any representation to the effect that the occurrence or growth of cancer or any medical condition can be prevented or successfully treated by any means whatsoever unless the respondent:

3.3 first has obtained:

3.3.1 from a person then registered with a medical practitioners board to practice medicine in Australia; or

3.3.2 from a professor, associate professor, reader, senior lecturer, or lecturer then teaching or researching in medicine at an Australian university;

written advice certifying that the proposed treatment is in the opinion of that person supported by reliable scientific evidence or expert medical opinion and is believed to be effective and safe; and

3.4. at the time of making the representation, prominently discloses details of the said advice, including the name, qualifications and position of the person providing the said advice; and

3.5. retains a copy of the said advice and provides a copy of the same to the applicant within 7 days of him receiving the certificate.

Ancillary Relief

4. Should the respondent become aware that any natural person or entity is:

4.1. representing expressly or impliedly to be him, or to be associated with him, or to be acting with his consent or on his behalf; and

4.2. making a representation in circumstances that, if made by the respondent would contravene paragraph 2 of these orders;

the respondent shall forthwith:

4.3. fully inform the applicant of those matters;

4.4. take all steps reasonably available to him to cause the person or entity to cease representing themselves to be him or to be associated with him, or to be acting with his consent, or on his behalf as the case may be, and to cease making representations referred to in paragraph 4.2 above;

4.5. furnish a copy of these orders to the person or entity as soon as he is able to do so and inform the person or entity that the person or entity may be committing contempt of these orders by their actions;

4.6. inform the applicant in writing that he has taken the steps required by paragraph 4.5 of these orders as soon as he has done so; and

4.7. refuse to treat and refuse to accept any payment from any person who, to the respondent's knowledge, sought his services as a result of the making of representations of the type referred to in paragraphs 4.1 and 4.2 of these orders.

5. The respondent, at his own expense, shall, within 7 days of this order, cause a notice in the form of Schedule 1 attached hereto to be published and to remain continuously in place, for a period of 3 months from the date of this order, on the home page of the following websites:

5.1. www.darryljoneshealth.com.au; and

5.2. any other website that at the date of this order is, or within 3 months of the date of this order becomes, controlled, owned, operated or maintained by the respondent that offers or promotes goods or services associated with the treatment or prevention of cancer or any other medical condition whatsoever;

and shall take all reasonable steps to ensure that such notice shall:

5.3. be a size that consists of at least 40% of the web page;

5.4. be published on the web page in text format;

5.5. be clearly viewable immediately on screen after the web page is accessed;

5.6. not be blocked by a pop up blocker;

5.7. remain on screen until closed by the person accessing that website; and

5.8. not require a further selection of hyperlinks or scrolling on the screen to be seen.

Note:

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.